NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

LIVN

LivaNova PLC

Jul 01 • 12:16PM ET

46.09

Dollar change +1.07
Percentage change 2.37	%

Healthcare • Medical Devices • United Kingdom • NASD

Peers: ABT MDT EW BSX SYK ZBH PODD GMED NVCR TMDX

| Held by: IJH IWM VXF IWN MDY IHI VTWO SCHA SPMD DFAT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.09	Insider Own	0.42%	Shs Outstand	54.52M	Perf Week	0.12%
Market Cap	2.51B	Forward P/E	11.70	EPS next Y	3.94	Insider Trans	0.00%	Shs Float	54.30M	Perf Month	6.56%
Enterprise Value	2.45B	PEG	-	EPS next Q	0.87	Inst Own	101.13%	Short Float	4.09%	Perf Quarter	17.33%
Income	-222.14M	P/S	1.97	EPS this Y	7.86%	Inst Trans	-1.49%	Short Ratio	2.86	Perf Half Y	-2.07%
Sales	1.28B	P/B	2.43	EPS next Y	8.07%	ROA	-8.85%	Short Interest	2.22M	Perf YTD	-0.48%
Book/sh	18.97	P/C	3.40	EPS next 5Y	8.71%	ROE	-19.69%	52W High	57.35 -19.64%	Perf Year	-15.95%
Cash/sh	13.54	P/FCF	17.27	EPS past 3/5Y	- -	ROIC	-13.68%	52W Low	32.48 41.89%	Perf 3Y	-28.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	6.58% 2.94%	Gross Margin	69.45%	Volatility	2.76% 2.46%	Perf 5Y	-2.99%
Dividend TTM	-	EV/Sales	1.92	EPS Y/Y TTM	-592.40%	Oper. Margin	-14.31%	ATR (14)	1.27	Perf 10Y	-25.75%
Dividend Ex-Date	-	Quick Ratio	1.37	Sales Y/Y TTM	7.97%	Profit Margin	-17.42%	RSI (14)	58.10	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	1.58	EPS Q/Q	-674.48%	SMA20	0.95%	Beta	0.91	Target Price	62.78
Payout	0.00%	Debt/Eq	0.66	Sales Q/Q	8.84%	SMA50	7.78%	Rel Volume	0.28	Prev Close	45.02
Employees	2900	LT Debt/Eq	0.57	Earnings	May 07 BMO	SMA200	-0.23%	Avg Volume	777.40K	Price	46.09
IPO	Feb 11, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	15.47% 4.79%	Trades		Volume	100,225	Change	2.37%

Date	Action	Analyst	Rating Change	Price Target Change
May-20-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$60
Feb-26-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Oct-04-24	Initiated	Goldman	Buy	$65
Sep-17-24	Upgrade	Robert W. Baird	Neutral → Outperform	$55 → $66
Mar-20-24	Reiterated	Needham	Buy
Feb-20-24	Upgrade	Mizuho	Neutral → Buy	$60 → $70
Sep-06-23	Initiated	HSBC Securities	Hold	$52
Jul-19-23	Initiated	Robert W. Baird	Neutral	$56
Apr-14-23	Initiated	Mizuho	Neutral	$48
Dec-21-22	Initiated	Barclays	Equal Weight	$62
Apr-06-22	Initiated	Wolfe Research	Outperform	$95
Feb-24-22	Upgrade	UBS	Neutral → Buy	$96
Dec-03-21	Initiated	Goldman	Buy	$108
Aug-20-21	Reiterated	Needham	Buy	$104 → $117
Jul-20-21	Upgrade	Needham	Hold → Buy	$93
Mar-03-21	Downgrade	Berenberg	Buy → Hold	$84
Jan-05-21	Downgrade	Needham	Buy → Hold
Sep-02-20	Initiated	Robert W. Baird	Outperform	$55
Jun-26-20	Reiterated	Needham	Buy	$84 → $76
Oct-30-19	Reiterated	Needham	Buy	$91 → $88

Show Previous Ratings

Jun-25-25 11:37AM	Are Options Traders Betting on a Big Move in LivaNova Stock? (Zacks)
Jun-10-25 08:33PM	Analyst Report: LivaNova PLC (Morningstar Research)
Jun-06-25 09:58AM	LivaNova completes epilepsy treatment study of VNS Therapy (Medical Device Network)
Jun-05-25 08:15AM	CORE-VNS Study Further Validates Effectiveness of LivaNovas VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy (Business Wire)
08:00AM	LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy (Business Wire)
08:00AM	Loading…
Jun-04-25 08:00AM	LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression (Business Wire)
May-15-25 08:00AM	LivaNova to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-08-25 03:10AM	LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances (GuruFocus.com)
May-07-25 11:31AM	Analyst Report: LivaNova PLC (Morningstar Research) +23.72%
07:15AM	LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates (Zacks)
06:14AM	LivaNova: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance (Business Wire)
05:45AM	LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy (Business Wire)
May-06-25 06:05PM	Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates (Zacks)
May-01-25 05:15PM	DexCom (DXCM) Q1 Earnings Miss Estimates (Zacks)
04:30PM	Loading…
Apr-25-25 04:30PM	Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now? (Insider Monkey)
Apr-14-25 09:51AM	LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires (Insider Monkey)
Apr-10-25 04:32AM	LivaNova PLC: Excellent Revenue Earner, Some Short-Term Litigation Concerns (Seeking Alpha)
Mar-26-25 08:00AM	LivaNova to Announce First-Quarter 2025 Results (Business Wire)
Mar-04-25 11:56PM	Is LivaNova PLC (LIVN) the Best Medical Technology Stock to Buy According to Analysts? (Insider Monkey)
10:12PM	Analyst Report: LivaNova PLC (Morningstar Research)
Feb-26-25 02:04AM	LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... (GuruFocus.com)
Feb-25-25 08:32PM	Analyst Report: LivaNova PLC (Morningstar Research) -15.76%
07:10AM	LivaNova (LIVN) Tops Q4 Earnings Estimates (Zacks)
06:10AM	LivaNova: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance (Business Wire)
Feb-21-25 12:39PM	Getinges surgical perfusion market exit opens door for LivaNova (Medical Device Network)
09:00AM	LivaNova to Present at the Barclays Global Healthcare Conference (Business Wire)
Feb-13-25 05:32AM	Getinge plans to leave surgical perfusion (Medical Device Network)
Jan-23-25 10:25AM	Should You Sell LivaNova PLC (LIVN)? (Insider Monkey)
09:00AM	Loading…
Jan-21-25 09:00AM	LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results (Business Wire)
Jan-14-25 11:18AM	Analyst Report: LivaNova PLC (Morningstar Research)
Jan-06-25 09:00AM	LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer (Business Wire)
Dec-18-24 08:30AM	RECOVER Clinical Study Shows Meaningful Benefits of LivaNovas VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression (Business Wire)
Dec-05-24 09:00AM	LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting (Business Wire)
Nov-28-24 09:55AM	Wall Street Analysts Predict a 37.2% Upside in LivaNova (LIVN): Here's What You Should Know (Zacks)
Nov-14-24 09:00AM	LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences (Business Wire)
Nov-13-24 06:16AM	Livanova hits sleep apnea trial goals, plans FDA filing (MedTech Dive)
06:16AM	Livanova hits goals in sleep apnea implant trial, plans FDA filing (MedTech Dive)
05:57AM	Goldman Sachs Says Improving Growth Could Propel These 2 Stocks Higher (TipRanks)
Nov-11-24 04:05PM	LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints (Business Wire)
Nov-07-24 12:00PM	LivaNova (LIVN) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	How Much Upside is Left in LivaNova (LIVN)? Wall Street Analysts Think 38.2% (Zacks)
Nov-03-24 01:37PM	Is a LivaNova PLC (LIVN) Promising Medical Stock with Growth Potential? (Insider Monkey)
Oct-31-24 08:31AM	Analyst Report: LivaNova PLC (Morningstar Research)
07:00AM	LivaNova PLC (LIVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
Oct-30-24 07:15AM	LivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:15AM	LivaNova: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Third-Quarter 2024 Results (Business Wire)
Oct-09-24 03:30PM	LivaNova PLC (LIVN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Oct-08-24 09:00AM	LivaNova Appoints Susan Podlogar as a New Director (Business Wire)
Sep-25-24 09:00AM	LivaNova to Announce Third-Quarter 2024 Results (Business Wire)
Sep-14-24 01:51AM	Insider Sale: Director Francesco Bianchi Sells 1,500 Shares of LivaNova PLC (LIVN) (GuruFocus.com)
Sep-12-24 04:02PM	Analyst Report: LivaNova PLC (Morningstar Research)
Aug-28-24 07:13PM	Analyst Report: LivaNova PLC (Morningstar Research)
Aug-27-24 07:15PM	Analyst Report: LivaNova PLC (Morningstar Research)
Aug-26-24 07:15PM	Analyst Report: LivaNova PLC (Morningstar Research)
Aug-19-24 09:00AM	LivaNova to Present at the Baird Global Healthcare Conference (Business Wire)
Aug-12-24 08:12PM	Analyst Report: LivaNova PLC (Morningstar Research)
Jul-31-24 02:00PM	Analyst Report: LivaNova PLC (Morningstar Research)
07:10AM	LivaNova (LIVN) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:10AM	LivaNova: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Second-Quarter 2024 Results (Business Wire)
Jun-18-24 09:00AM	LivaNova to Announce Second-Quarter 2024 Results (Business Wire)
Jun-08-24 10:08PM	Top 50 Companies in London (Insider Monkey)
Jun-06-24 07:45PM	Analyst Report: LivaNova PLC (Morningstar Research) -12.04%
09:00AM	LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients (Business Wire)
May-23-24 09:00AM	LivaNova to Present at the Goldman Sachs Healthcare Conference (Business Wire)
May-02-24 11:50AM	LivaNova PLC (NASDAQ:LIVN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 08:12PM	Analyst Report: LivaNova PLC (Morningstar Research) +12.32%
09:59AM	LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance (MT Newswires)
07:33AM	LivaNova PLC (LIVN) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
07:10AM	LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates (Zacks)
06:11AM	LivaNova: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports First-Quarter 2024 Results (Business Wire)
Apr-30-24 09:00AM	LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer (Business Wire)
Apr-26-24 12:34PM	Livanova says patient data obtained in 2023 cyberattack (MedTech Dive)
07:21AM	LivaNova gives notice of personal patient data compromised by hackers (Medical Device Network)
Apr-25-24 04:03PM	LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident (Business Wire)
Apr-24-24 10:01AM	LivaNova (LIVN) Earnings Expected to Grow: Should You Buy? (Zacks)
Mar-21-24 09:00AM	LivaNova to Announce First-Quarter 2024 Results (Business Wire)
04:46AM	LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock? (Zacks)
Mar-20-24 09:00AM	LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea (Business Wire) +12.50%
Mar-05-24 09:55PM	LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029 (Business Wire) -6.21%
Mar-04-24 04:44PM	LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes (Business Wire)
09:00AM	LivaNova to Present at the Barclays Global Healthcare Conference (Business Wire)
Feb-22-24 09:58AM	LivaNova PLC (NASDAQ:LIVN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-21-24 03:15PM	Analyst Report: LivaNova PLC (Morningstar Research) +8.02%
07:10AM	LivaNova (LIVN) Q4 Earnings and Revenues Top Estimates (Zacks)
06:32AM	LivaNova PLC (LIVN) Posts Double-Digit Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
06:11AM	LivaNova: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LivaNova Reports Fourth-Quarter and Full-Year 2023 Results (Business Wire)
Feb-13-24 01:04PM	PRIMECAP Management Bolsters Stake in LivaNova PLC (GuruFocus.com)
Feb-09-24 04:34AM	Livanova to lay off 137 people at Pittsburgh facility (MedTech Dive)
Feb-06-24 06:15AM	Livanova names J&J veteran Vladimir Makatsaria as CEO (MedTech Dive)
Feb-05-24 08:00AM	LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director (Business Wire)
Jan-10-24 05:00AM	Livanova to close loss-making circulatory support business (MedTech Dive)
Jan-08-24 08:30AM	LivaNova to Wind Down Advanced Circulatory Support Business Unit (Business Wire) +6.89%
Jan-04-24 09:00AM	LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results (Business Wire)
Dec-12-23 08:02PM	Analyst Report: LivaNova PLC (Morningstar Research) +7.58%

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
O'Kane Sharon	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	12,910	Jun 17 04:55 PM
Bianchi Francesco	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	10,938	Jun 17 04:54 PM
SCHERMERHORN TODD C	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	9,473	Jun 17 04:54 PM
KOZY WILLIAM A	Director	Jun 15 '25	Option Exercise	0.00	4,840	0	33,148	Jun 17 04:54 PM
Barry James Christopher	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	4,772	Jun 17 04:54 PM
Story Brooke	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	6,892	Jun 17 04:54 PM
Enxing Seng Stacy	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	12,161	Jun 17 04:54 PM
WILVER PETER M	Director	Jun 15 '25	Option Exercise	0.00	3,416	0	7,148	Jun 17 04:54 PM
Tezel Ahmet	Chief Innovation Officer	Jun 15 '25	Option Exercise	0.00	2,967	0	2,967	Jun 17 04:53 PM
Bolton Stephanie	President, Global Epilepsy	Mar 30 '25	Option Exercise	0.00	6,024	0	15,586	Apr 01 09:01 PM
Makatsaria Vladimir	Chief Executive Officer	Mar 30 '25	Option Exercise	0.00	9,330	0	9,330	Apr 01 09:01 PM
KOZY WILLIAM A	Director	Mar 30 '25	Option Exercise	0.00	1,034	0	28,496	Apr 01 09:01 PM
Hutchinson Michael Damon	Chief Legal Officer	Mar 30 '25	Option Exercise	0.00	2,930	0	6,686	Apr 01 09:00 PM
Shvartsburg Alex	Chief Financial Officer	Mar 30 '25	Option Exercise	0.00	11,083	0	30,196	Apr 01 09:00 PM
Poletti Franco	President, Cardiopulmonary	Mar 30 '25	Option Exercise	0.00	1,257	0	8,475	Apr 01 09:00 PM
Hutchinson Michael Damon	Chief Legal Officer	Dec 15 '24	Option Exercise	0.00	2,254	0	4,540	Dec 17 05:23 PM
Poletti Franco	President, Cardiopulmonary	Dec 15 '24	Option Exercise	0.00	967	0	7,634	Dec 17 05:23 PM
Barry James Christopher	Director	Dec 15 '24	Option Exercise	0.00	1,709	0	1,709	Dec 17 05:22 PM
Shvartsburg Alex	Chief Financial Officer	Dec 15 '24	Option Exercise	0.00	613	0	19,342	Dec 17 05:22 PM
Bianchi Francesco	Director	Dec 11 '24	Sale	50.99	1,250	63,738	7,522	Dec 13 04:03 PM
Bianchi Francesco	Director	Dec 11 '24	Proposed Sale	50.99	1,250	63,738		Dec 11 04:40 PM
Hebbelinck Trui	Officer	Dec 10 '24	Proposed Sale	50.27	6,000	301,621		Dec 10 05:30 PM
Bianchi Francesco	Director	Sep 11 '24	Sale	46.58	1,500	69,870	8,772	Sep 13 04:13 PM
Bianchi Francesco	Director	Sep 11 '24	Proposed Sale	46.58	1,500	69,870		Sep 11 04:58 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LIVN

LivaNova PLC

Upgrade your FINVIZ experience